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background:  Significant racial/ethnic differences exist in the incidence of atrial fibrillation (AF). However, less is known about racial/ethnic 
differences in clinical presentation, management, and outcomes associated with AF.
Methods:  Using data from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF), we compared clinical characteristics 
and management strategies associated with AF among various racial/ethnic groups. We also compared long-term outcomes among these 
groups using multivariable cox models.
results:  We analyzed 9,542 participants with AF [mean age: 74±11 years, 43% women, 91% white, 5% black, 4% Hispanic] from 174 
participating centers. Compared to white patients, Hispanic and black patients with AF were younger, more often women, and more likely 
to have associated cardiac and non-cardiac risk factors. Black patients were more symptomatic, but were less likely to be treated with a 
rhythm control strategy than white patients. There were no significant differences in CHADS2VASc stroke or ATRIA bleeding risk scores, 
oral anticoagulant use, and long-term outcomes associated with AF between the three groups at a median follow up of 2.1 years (Table).
Conclusion:  Predicted stroke and bleeding risks, oral anticoagulation use and long-term outcomes associated with AF are comparable 
among white, black, and Hispanic patients despite significant differences in risk factor burden, symptom prevalence, and management 
strategies.
 
